Combined survival analysis of cardiac patients by a Cox PH model and a Markov chain

Michal Shauly1, Gad Rabinowitz, Harel Gilutz

  • 1Department of Industrial Engineering and Management, Ben-Gurion University of the Negev, P.O. Box 653, Beer-Sheva 84105, Israel. shauly@bgu.ac.il

Insights

This study introduces a novel framework combining Cox PH and Markov models to analyze cardiac patient survival. The findings highlight key risk factors and the survival benefits of statin use in coronary heart disease patients.

Area of Science:

  • Cardiovascular Medicine
  • Biostatistics
  • Public Health

Background:

  • Dyslipidemia management is crucial for patients with coronary heart diseases, posing a significant public health challenge.
  • Understanding factors influencing survival after major cardiac events is essential for effective patient care and disease prevention.

Purpose of the Study:

  • To develop and validate a combined Cox Proportional Hazards (PH) model and Markov chain framework for survival analysis in cardiac patients.
  • To assess the impact of changing Low-Density Lipoprotein (LDL)-cholesterol levels and statin consumption on patient survival post-cardiac event.

Main Methods:

  • Prospective study of 2,277 cardiac patients.
  • Application of a combined framework integrating Cox PH model and Markov chain analysis.
  • Evaluation of factors affecting survival time, hazard rates, and long-term outcomes.

Main Results:

  • High congruence observed between the Markov and Cox PH models.
  • Diabetes, history of stroke, peripheral vascular disease, and smoking were identified as significant predictors of increased hazard rate and reduced survival time.
  • Statin consumption was consistently correlated with a lower hazard rate and longer survival time across both models.

Conclusions:

  • The proposed framework effectively integrates different modeling approaches to provide robust conclusions on survival factors in cardiac patients.
  • Findings underscore the importance of managing comorbidities and lifestyle factors (e.g., smoking) alongside statin therapy for improving cardiac patient survival.
  • The framework offers valuable insights for understanding therapeutic behaviors and implementing targeted secondary and primary prevention strategies for heart diseases.

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of interest.
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...